No Data
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
Revolution Medicines(RVMD.US) Officer Sells US$58,670.87 in Common Stock
$Revolution Medicines(RVMD.US)$ Officer Cislini Jeff sold 1,500 shares of common stock on May 21, 2024 at an average price of $39.1139 for a total value of $58,670.87.Source: Announcement What is stat
Oppenheimer Remains a Buy on Revolution Medicines (RVMD)
Express News | HC Wainwright & Co. Reiterates Buy on Revolution Medicines, Maintains $44 Price Target
Buy Rating on Revolution Medicines With a $44 Target Amid Strong Financials and Upcoming Clinical Catalysts
Revolution Medicines Reports Q1 2024 Financial Results: Challenges and Strategic Advances in ...